EP3142690
COMBINATION THERAPY FOR TREATING CANCER WITH A RECOMBINANT POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN IMMUNE CHECKPOINT MOLECULE ANTAGONIST OR AGONIST
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.5.2015EP published:
23.2.2022EP application number:
15733563.9
EPO information:
European Patent Register
Max expiry date:
7.5.2035
Title in English:
COMBINATION THERAPY FOR TREATING CANCER WITH A RECOMBINANT POXVIRUS EXPRESSING A TUMOR ANTIGEN AND AN IMMUNE CHECKPOINT MOLECULE ANTAGONIST OR AGONISTLanguage of the patent:
English
Timeline
Today
8.5.2015EP application
23.2.2022EP Publication
Owner
Name:
Bavarian Nordic A/SAddress:
Hejreskovvej 10A, 3490 Kvistgaard, DK
Inventor
Name:
FOY, SusanAddress:
Mountain View, CA 94041, US
Name:
MANDL, StefanieAddress:
San Francisco, CA 94122, US
Name:
ROUNTREE, RyanAddress:
San Jose, CA 95118, US
Name:
FRANZUSOFF, AlexAddress:
El Granada, CA 94018, US
Priority
Number:
201461992788 PDate:
13.5.2014Country:
US
Classification
Categories:
A61K 39/00, A61K 39/39